Covid-19 updates: Vaccine maker seeks to launch study; Gilead asks for remdesivir approval

Gilead's formal FDA nod of remdesivir, branded as Veklury, is likely given its conditional approval since May during the Covid pandemic. Vaxart is asking to start an early-stage study of its experimental Covid vaccine.